Chief Innovation Officer Andreas Busch bought 100,000 ABSI shares at $2.29; holdings now 421,446 (+31.1%). Stock down -50.0% from 52-week high.
Andreas Busch, Chief Innovation Officer, purchased 100,000 shares at $2.29, increasing his holdings by 31.1% to 421,446 shares. The timing is notable: his prior purchase at ABSI in July 2025 achieved a 90-day return of +40.5%, and his cross-ticker track record shows a 100% win rate on buys at the 90-day mark, averaging +40.5% over that horizon. However, current context is materially weaker—the stock trades at $2.50, down -50.0% from the $5.00 52-week high and -29.6% over the past 90 days. The company is unprofitable (net income $-28.7M in the latest quarter) with declining revenue (-20.7% year-over-year). The purchase occurs in a depressed price environment relative to recent history, but against deteriorating operational fundamentals.
Chief Innovation Officer Busch Andreas buys 50,000 shares at $3.04 amid -20.7% annual revenue decline and -26.3M net loss.
Busch Andreas, Chief Innovation Officer, purchased 50,000 shares at $3.04 on 2025-07-28, increasing his holdings by 18.0% to 327,264 shares post-transaction. The purchase occurs while Absci Corp faces significant operational headwinds: annual revenue declined 20.7% year-over-year, the company posted a full-year net loss of -26.3M, and the current stock price of $2.95 is -49.3% from the 52-week high of $5.82. Despite the transaction occurring at $3.04, which is above the current market price, the broader context reveals a company in financial distress. An insider investment during such deterioration warrants attention to whether this reflects confidence in a turnaround strategy aligned with his innovation leadership role, or whether it represents an isolated personal allocation decision disconnected from the company's trajectory.
